Extracellular deposition of amyloid fibrils is responsible for the pathology in the systemic amyloidoses and probably also in Alzheimer disease [Haass, C.
Amyloid fibrils are composed only of autologous proteins and glycosaminoglycans (1) , and they should therefore be degradable in vivo. Indeed, when production of the protein precursors of amyloid fibrils can be sufficiently reduced, specific noninvasive scintigraphic imaging of amyloid shows that the deposits do regress slowly over months or years (2) (3) (4) . There is also in vitro and neuropathologic evidence of a dynamic balance between deposition and resolution of the cerebral amyloid 1 protein (A3) lesions in Alzheimer disease (5, 6) . The usual apparent irreversibility of amyloid in clinical practice thus largely reflects the progressive nature of the incurable conditions that underlie most forms of amyloidosis. However, there are also likely to be mechanisms other than the intrinsic properties of the fibrils that contribute to their persistence in vivo.
Serum amyloid P component (SAP) is a universal constituent of amyloid deposits in vivo (1) , including the plaques, amorphous A3 deposits, and neurofibrillary tangles of Alzheimer disease (7) (8) (9) (10) (11) (12) (13) (14) . It undergoes reversible calcium-dependent binding to all types of amyloid fibrils in vitro (15) and comprises up to 15% of the mass of amyloid deposits in vivo (16) . This remarkable specific concentration of a trace plasma protein (20) (21) (22) (23) (24) (25) (26) (27) (28) (29) (30) mg/liter) contrasts with the very small quantities in amyloid deposits of other, much more abundant, plasma and extracellular fluid proteins: apolipoprotein E (17) , al-antichymotrypsin (18) , and some complement components
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United Kingdom, February 6, 1995 (received for review (19) . Although the physiological role of SAP is not known, we have previously proposed that SAP might protect amyloid from degradation in vivo by masking the abnormal fibrillar conformation that would otherwise be expected to trigger phagocytic clearance mechanisms (20) (21) (22) . Indeed, SAP isolated from amyloid deposits is identical to circulating SAP (23) . Furthermore, SAP molecules deposited in amyloid are not catabolized and are broken down only when they return to the circulation (24) . The only significant site of in vivo catabolism of SAP is the hepatocyte (25) , suggesting that other cells, especially phagocytes, lack receptors for SAP. In addition, SAP is highly resistant to proteolysis (26) , probably because of its flattened 13-jelly roll structure in which the 1-strands are joined by compact loops tightly bonded to the body of the oligomeric assembly (27) .
Prompted (20, 28) .
MATERIALS AND METHODS
Reagents. Amyloid fibrils were isolated from amyloidotic spleens of patients with amyloid A (AA), monoclonal immunoglobulin light chain (29) , and apolipoprotein AI Arg-60 amyloidosis (30) by water extraction (31) after repeated homogenization of the tissue in 10 mM Tris-HCl/138 mM NaCl/10 mM EDTA/0.1% NaN3, pH 8.0 (TE buffer) to remove endogenous SAP (32) , and some were radiolabeled with 125I (33 (34) . MO3DG was synthesized as reported (28) and freshly dissolved in 10 mM Tris.HCl/138 mM NaCl, pH 8 .0 (TN buffer). SAP and C-reactive protein (CRP) were isolated in pure form as described (35) (36) (37) . In the absence of physiological concentrations of albumin or of a specific ligand, isolated SAP precipitates in the presence of calcium (38) (Fig. 2) .
Binding of SAP to Amyloid Fibrils. SAP showed reversible calcium-dependent binding to ex vivo amyloid fibrils and this was inhibited by MOPDG, as reported (15, 28) (Fig. 3) . SAP also showed saturable binding to synthetic AP fibrils, reaching a plateau at a molar ratio of -1 mol of SAP (Mr, 254,620) per 500 mol of A3 (Mr, 4330), compatible with interaction between decameric SAP and fibrillar aggregates of AP3 (Fig. 4) . The mass of SAP present at saturation corresponded to -12% that of the fibrils and was comparable to their relative proportions in amyloid deposits in vivo (16 (26), are stabilized by the electrostatic and hydrogen bonds (27) (21) (unpublished data). In the present experiments, SAP prevented digestion of fibrils only when bound to them. In the presence of the cyclic pyruvate acetal, MO3DG, which is the most specific carbohydrate ligand of SAP and inhibits its binding to amyloid fibrils (20, 28) , SAP had no effect. SAP is thus not an enzyme inhibitor per se. CRP, another highly proteinase-resistant molecule (42) 
